07 Nov The Bulgarian Drug Agency issued a new marketing authorization for the medicinal product Linezolid-Tchaikapharma
The newest medicinal product placed on the market after having received a marketing authorization from the Bulgarian Drug Agency by the Ministry of Health is the infusion solution Linezolid-Tchaikapharma 2 mg/ml.
Its active substance is linezolid, and a packaging contents 300 ml x 5 pcs. or 10 pcs.
This medicinal product is used in cases of hospital- or community-acquired pneumonias, where they are known or suspected to be caused by sensitive Gram-positive bacteria.
Linezolid-Tchaikapharma is subject to medical prescription.
ATC code: J01XX 08